Nova Eye Medical LtdASX: EYE

First Sale iTrack Advance in South Korea

· Issued by Nova Eye Medical Ltd via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Nova Eye Medical Ltd has announced its first commercial sale of iTrack™ Advance in South Korea, marking a significant milestone for the company. This sale follows regulatory clearance from the Ministry of Food and Drug Safety and pricing approval under South Korea’s National Health Insurance system. Sales are expected to contribute to revenue growth in the upcoming fiscal year through an established distribution partner.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX RELEASE 11 November 2026 First Sale of iTrack™ Advance in South Korea Highlights • First commercial sale of iTrack™ Advance made in South Korea during the first week of November 2026. • Follows regulatory clearance from the Ministry of Food and Drug Safety (MFDS) in mid-2025 and...

Nova Eye Medical Ltd on 6ix

Earlier from Nova Eye Medical

Later from Nova Eye Medical

All Nova Eye Medical news releases